AG2R LA Mondiale Gestion D Actifs Makes New Investment in GE HealthCare Technologies Inc. $GEHC

Key Points

• AG2R LA Mondiale Gestion D Actifs made a new investment of $1.54 million in GE HealthCare Technologies, acquiring 19,085 shares of the company in the 1st quarter.
• GE HealthCare Technologies reported a quarterly earnings per share (EPS) of $1.06, exceeding the consensus estimate, and had a revenue of $5 billion for the quarter.
• Several analysts upgraded GE HealthCare Technologies' stock rating, with Wall Street Zen moving it from "hold" to "buy" and setting an average price target of $88.40.

AG2R LA Mondiale Gestion D Actifs acquired a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the first quarter, according to the company in its most recent filing with the SEC. The fund acquired 19,085 shares of the company's stock, valued at approximately $1,540,000.

Other hedge funds also recently added to or reduced their stakes in the company. N.E.W. Advisory Services LLC acquired a new position in GE HealthCare Technologies during the 1st quarter worth $25,000. Bogart Wealth LLC grew its holdings in GE HealthCare Technologies by 260.0% during the 1st quarter. Bogart Wealth LLC now owns 342 shares of the company's stock worth $28,000 after acquiring an additional 247 shares in the last quarter. Stonebridge Financial Group LLC boosted its holdings in shares of GE HealthCare Technologies by 165.7% in the 1st quarter. Stonebridge Financial Group LLC now owns 356 shares of the company's stock valued at $29,000 after buying an additional 222 shares during the period. Ameriflex Group Inc. acquired a new position in shares of GE HealthCare Technologies in the 4th quarter valued at about $31,000. Finally, Olde Wealth Management LLC acquired a new position in shares of GE HealthCare Technologies in the 1st quarter valued at about $35,000. 82.06% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

GEHC has been the subject of several research reports. Citigroup lifted their price target on shares of GE HealthCare Technologies from $89.00 to $93.00 and gave the company a "buy" rating in a report on Thursday, July 31st. BTIG Research reaffirmed a "buy" rating on shares of GE HealthCare Technologies in a report on Monday, July 14th. Morgan Stanley decreased their price target on shares of GE HealthCare Technologies from $78.00 to $74.00 and set an "equal weight" rating for the company in a report on Thursday, July 31st. Wall Street Zen raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating in a report on Saturday, May 31st. Finally, Zacks Research raised shares of GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a report on Thursday, August 28th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $88.40.

GE HealthCare Technologies Stock Performance

GE HealthCare Technologies stock traded down $1.12 during midday trading on Thursday, reaching $75.51. 1,031,293 shares of the stock traded hands, compared to its average volume of 3,937,378. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85. The firm has a fifty day moving average price of $74.59 and a two-hundred day moving average price of $73.42. The firm has a market cap of $34.47 billion, a price-to-earnings ratio of 15.51, a PEG ratio of 2.96 and a beta of 1.13. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.91 by $0.15. The firm had revenue of $5 billion during the quarter, compared to analyst estimates of $4.96 billion. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. GE HealthCare Technologies's revenue was up 3.5% on a year-over-year basis. During the same period in the previous year, the business posted $1.00 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 25th were given a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date was Friday, July 25th. GE HealthCare Technologies's payout ratio is 2.87%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.